Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2019

01-01-2019 | Original Article

Sodium Butyrate Enhances Intestinal Riboflavin Uptake via Induction of Expression of Riboflavin Transporter-3 (RFVT3)

Authors: Veedamali S. Subramanian, Subrata Sabui, Christopher W. Heskett, Hamid M. Said

Published in: Digestive Diseases and Sciences | Issue 1/2019

Login to get access

Abstract

Background

Uptake of riboflavin (RF) by intestinal epithelial cells occurs via a specific carrier-mediated process that involves the apically localized RF transporter-3 (RFVT3). Previous studies have shown that sodium butyrate (NaB) affects intestinal uptake of other substrates and expression of their membrane transporters, but its effect on intestinal uptake of RF and expression of RFVT3 has not been examined.

Aims

To investigate the effect of NaB on intestinal RF uptake process and expression of the RFVT3.

Methods

Two experimental models were used in this study: Human-derived intestinal epithelial Caco-2 cells and ex vivo mouse colonoids. 3H-RF uptake assay, Western blot, RT-qPCR, and chromatin immunoprecipitation assay were performed.

Results

Treating Caco-2 cells with NaB led to a significant increase in carrier-mediated RF uptake. This increase was associated with a significant induction in the level of expression of the hRFVT3 protein, mRNA, and heterogenous nuclear RNA (hnRNA). Similarly, treating mouse colonoids with NaB led to a marked increase in the level of expression of the mRFVT3 protein, mRNA, and hnRNA. NaB did not affect hRFVT3 mRNA stability, rather it caused significant epigenetic changes (histone modifications) in the SLC52A3 gene where an increase in H3Ac and a reduction in H3K27me3 levels were observed in the NaB-treated Caco-2 cells compared to untreated controls.

Conclusion

These findings demonstrate that NaB up-regulates intestinal RF uptake and that the effect appears to be mediated, at least in part, at the level of transcription of the SLC52A3 gene and may involve epigenetic mechanism(s).
Literature
1.
go back to reference Cooperman JM, Lopez R. Riboflavin. In: Machlin LJ, ed. Handbook of Vitamins: Nutritional, Biochemical and Clinical Aspects. New York: Dekker; 1984:299–327. Cooperman JM, Lopez R. Riboflavin. In: Machlin LJ, ed. Handbook of Vitamins: Nutritional, Biochemical and Clinical Aspects. New York: Dekker; 1984:299–327.
2.
go back to reference Tu BP, Ho-Schleyer SC, Travers KJ, Weissman JS. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science. 2000;290:1571–1574.CrossRef Tu BP, Ho-Schleyer SC, Travers KJ, Weissman JS. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science. 2000;290:1571–1574.CrossRef
3.
go back to reference Sanches SC, Ramalho LN, Mendes-Bras M, et al. (vitamin B-2) reduces hepatocellular injury following liver ischaemia and reperfusion in mice. Food Chem Toxicol. 2014;67:65–71.CrossRef Sanches SC, Ramalho LN, Mendes-Bras M, et al. (vitamin B-2) reduces hepatocellular injury following liver ischaemia and reperfusion in mice. Food Chem Toxicol. 2014;67:65–71.CrossRef
4.
go back to reference Liu D, Zempleni J. Low activity of LSD1 elicits a pro-inflammatory gene expression profile in riboflavin-deficient human T Lymphoma Jurkat cells. Genes Nutr. 2014;9:422.CrossRef Liu D, Zempleni J. Low activity of LSD1 elicits a pro-inflammatory gene expression profile in riboflavin-deficient human T Lymphoma Jurkat cells. Genes Nutr. 2014;9:422.CrossRef
5.
go back to reference Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol. 2013;14:676–684.CrossRef Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol. 2013;14:676–684.CrossRef
6.
go back to reference Mazur-Bialy AI, Buchala B, Plytycz B. Riboflavin deprivation inhibits macrophage viability and activity—a study on the RAW 264.7 cell line. Br J Nutr. 2013;110:509–514.CrossRef Mazur-Bialy AI, Buchala B, Plytycz B. Riboflavin deprivation inhibits macrophage viability and activity—a study on the RAW 264.7 cell line. Br J Nutr. 2013;110:509–514.CrossRef
7.
go back to reference Schramm M, Wiegmann K, Schramm S, et al. Riboflavin (vitamin B2) deficiency impairs NADPH oxidase 2 (Nox2) priming and defense against Listeria monocytogenes. Eur J Immunol. 2014;44:728–741.CrossRef Schramm M, Wiegmann K, Schramm S, et al. Riboflavin (vitamin B2) deficiency impairs NADPH oxidase 2 (Nox2) priming and defense against Listeria monocytogenes. Eur J Immunol. 2014;44:728–741.CrossRef
8.
go back to reference Fernandez-Banares F, Abad-Lacruz A, Xiol X, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol. 1989;84:744–748.PubMed Fernandez-Banares F, Abad-Lacruz A, Xiol X, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol. 1989;84:744–748.PubMed
9.
go back to reference Rosenthal WS, Adham NF, Lopez R, Cooperman JM. Riboflavin deficiency in complicated chronic alcoholism. Am J Clin Nutr. 1973;26:858–860.CrossRef Rosenthal WS, Adham NF, Lopez R, Cooperman JM. Riboflavin deficiency in complicated chronic alcoholism. Am J Clin Nutr. 1973;26:858–860.CrossRef
10.
go back to reference Kodentsova VM, Vrzhesinskaia OA, Trofimenko EV, et al. The vitamin status of children with diabetes mellitus. Vopr Med Khim. 1994;40:45–48.PubMed Kodentsova VM, Vrzhesinskaia OA, Trofimenko EV, et al. The vitamin status of children with diabetes mellitus. Vopr Med Khim. 1994;40:45–48.PubMed
11.
go back to reference Bosch AM, Abeling NG, Ijlst L, et al. Brown–Vialetto–Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. J Inherit Metab Dis. 2011;34:159–164.CrossRef Bosch AM, Abeling NG, Ijlst L, et al. Brown–Vialetto–Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. J Inherit Metab Dis. 2011;34:159–164.CrossRef
12.
go back to reference Green P, Wiseman M, Crow YJ, et al. Brown–Vialetto–Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in C20orf54. Am J Hum Genet. 2010;86:485–489.CrossRef Green P, Wiseman M, Crow YJ, et al. Brown–Vialetto–Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in C20orf54. Am J Hum Genet. 2010;86:485–489.CrossRef
13.
go back to reference Ho G, Yonezawa A, Masuda S, et al. Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric gciduria type 2, 1s caused by a microdeletion in the riboflavin transporter gene GPR172B. Hum Mut. 2011;32:E1976–E1984.CrossRef Ho G, Yonezawa A, Masuda S, et al. Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric gciduria type 2, 1s caused by a microdeletion in the riboflavin transporter gene GPR172B. Hum Mut. 2011;32:E1976–E1984.CrossRef
14.
go back to reference Johnson JO, Gibbs JR, Megarbane A, et al. Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain. 2012;185:2875–2882.CrossRef Johnson JO, Gibbs JR, Megarbane A, et al. Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain. 2012;185:2875–2882.CrossRef
15.
go back to reference Iinuma S. Synthesis of riboflavin by intestinal bacteria. J Vitaminol. 1955;1:6–13. (Kyoto).CrossRef Iinuma S. Synthesis of riboflavin by intestinal bacteria. J Vitaminol. 1955;1:6–13. (Kyoto).CrossRef
16.
go back to reference Kasper H. Vitamin absorption in the colon. Am J Protocol. 1970;21:341–345. Kasper H. Vitamin absorption in the colon. Am J Protocol. 1970;21:341–345.
17.
go back to reference Said HM, Arianas P. Transport of riboflavin in human intestinal brush border membrane vesicles. Gastroenterology. 1991;100:82–88.CrossRef Said HM, Arianas P. Transport of riboflavin in human intestinal brush border membrane vesicles. Gastroenterology. 1991;100:82–88.CrossRef
18.
go back to reference Sorrell MF, Frank O, Thompson AD, Aquino A, Baker H. Absorption of vitamins from the large intestine. Nutr Rep Int. 1971;3:143–148. Sorrell MF, Frank O, Thompson AD, Aquino A, Baker H. Absorption of vitamins from the large intestine. Nutr Rep Int. 1971;3:143–148.
19.
go back to reference Middleton HM. Uptake of riboflavin by rat intestinal mucosa in vitro. J Nutr. 1985;120:588–593.CrossRef Middleton HM. Uptake of riboflavin by rat intestinal mucosa in vitro. J Nutr. 1985;120:588–593.CrossRef
20.
go back to reference Said HM, Ma TY. Regulation of riboflavine intestinal uptake by Caco-2 cells. Am J Physiol. 1994;266:G15–G21.PubMed Said HM, Ma TY. Regulation of riboflavine intestinal uptake by Caco-2 cells. Am J Physiol. 1994;266:G15–G21.PubMed
21.
go back to reference Said HM, Mohammadkhani R. Uptake of riboflavin across the brush border membrane of rat intestine: regulation by dietary vitamin levels. Gastroenterology. 1993;105:1294–1298.CrossRef Said HM, Mohammadkhani R. Uptake of riboflavin across the brush border membrane of rat intestine: regulation by dietary vitamin levels. Gastroenterology. 1993;105:1294–1298.CrossRef
22.
go back to reference Yamamoto S, Inoue K, Ohta KY, et al. Identification and functional characterization of rat riboflavin transporter 2. J Biochem. 2009;145:437–443.CrossRef Yamamoto S, Inoue K, Ohta KY, et al. Identification and functional characterization of rat riboflavin transporter 2. J Biochem. 2009;145:437–443.CrossRef
23.
go back to reference Yao Y, Yonezawa A, Yoshimatsu H, et al. Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain. J Nutr. 2010;140:1220–1226.CrossRef Yao Y, Yonezawa A, Yoshimatsu H, et al. Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain. J Nutr. 2010;140:1220–1226.CrossRef
24.
go back to reference Yonezawa A, Masuda S, Katsura T, Inui K. Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1. Am J Physiol Cell Physiol. 2008;295:C632–C641.CrossRef Yonezawa A, Masuda S, Katsura T, Inui K. Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1. Am J Physiol Cell Physiol. 2008;295:C632–C641.CrossRef
25.
go back to reference Yonezawa A, Inui K. Novel riboflavin transporter family RFVT/SLC52: identification, functional characterization and genetic diseases of RFVT/SLC52. Mol Aspects Med. 2013;34:693–701.CrossRef Yonezawa A, Inui K. Novel riboflavin transporter family RFVT/SLC52: identification, functional characterization and genetic diseases of RFVT/SLC52. Mol Aspects Med. 2013;34:693–701.CrossRef
26.
go back to reference Subramanian VS, Subramanya SB, Rapp L, et al. Differential expression of human riboflavin transporters -1, -2, and -3 in polarized epithelia: a key role for hRFT-2 in intestinal riboflavin uptake. Biochim Biophys Acta. 2011;1808:3016–3021.CrossRef Subramanian VS, Subramanya SB, Rapp L, et al. Differential expression of human riboflavin transporters -1, -2, and -3 in polarized epithelia: a key role for hRFT-2 in intestinal riboflavin uptake. Biochim Biophys Acta. 2011;1808:3016–3021.CrossRef
27.
go back to reference Subramanian VS, Lambrecht N, Lytle C, Said HM. Conditional (intestinal-specific) knockout of the riboflavin transporter-3 (RFVT-3) impairs riboflavin absorption. Am J Physiol Gastrointest Liver Physiol. 2016;310:G285–G293.CrossRef Subramanian VS, Lambrecht N, Lytle C, Said HM. Conditional (intestinal-specific) knockout of the riboflavin transporter-3 (RFVT-3) impairs riboflavin absorption. Am J Physiol Gastrointest Liver Physiol. 2016;310:G285–G293.CrossRef
28.
go back to reference Bosch AM, Stroek K, Abeling NG, et al. The Brown–Vialetto–Van Laere and Fazio Londe syndrome revised: natural history, genetics, treatment and future perspectives. Orphanet J Rare Dis.. 2012;7:83.CrossRef Bosch AM, Stroek K, Abeling NG, et al. The Brown–Vialetto–Van Laere and Fazio Londe syndrome revised: natural history, genetics, treatment and future perspectives. Orphanet J Rare Dis.. 2012;7:83.CrossRef
29.
go back to reference Cummings JH. Short chain fatty acids in the human colon. Gut. 1981;22:763–779.CrossRef Cummings JH. Short chain fatty acids in the human colon. Gut. 1981;22:763–779.CrossRef
30.
go back to reference Ganapathy V, Thangaraju M, Prasad PD, Martin PM, Singh N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol. 2013;13:869–874.CrossRef Ganapathy V, Thangaraju M, Prasad PD, Martin PM, Singh N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol. 2013;13:869–874.CrossRef
31.
go back to reference Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol. 1991;70:443–459.CrossRef Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol. 1991;70:443–459.CrossRef
32.
go back to reference Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28:1221–1227.CrossRef Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28:1221–1227.CrossRef
33.
go back to reference Wrong O, Metcalfe-gibson A, Morrison RB, Ng ST, Howard AV. In vivo dialysis of faeces as a method of stool analysis. i. technique and results in normal subjects. Clin Sci. 1965;28:357–375.PubMed Wrong O, Metcalfe-gibson A, Morrison RB, Ng ST, Howard AV. In vivo dialysis of faeces as a method of stool analysis. i. technique and results in normal subjects. Clin Sci. 1965;28:357–375.PubMed
34.
go back to reference Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980;21:793–798.CrossRef Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980;21:793–798.CrossRef
35.
go back to reference Dalmasso G, Nguyen HT, Yan Y, et al. Butyrate transcriptionally enhances peptide transporter PepT1 expression and activity. PLoS ONE. 2008;3:e2476.CrossRef Dalmasso G, Nguyen HT, Yan Y, et al. Butyrate transcriptionally enhances peptide transporter PepT1 expression and activity. PLoS ONE. 2008;3:e2476.CrossRef
36.
go back to reference Musch MW, Bookstein C, Xie Y, Sellin JH, Chang EB. SCFA increase intestinal Na absorption by induction of NHE3 in rat colon and human intestinal C2/bbe cells. Am J Physiol Gastrointest Liver Physiol. 2001;280:G687–G693.CrossRef Musch MW, Bookstein C, Xie Y, Sellin JH, Chang EB. SCFA increase intestinal Na absorption by induction of NHE3 in rat colon and human intestinal C2/bbe cells. Am J Physiol Gastrointest Liver Physiol. 2001;280:G687–G693.CrossRef
37.
go back to reference Xu H, McCoy A, Li J, Zhao Y, Ghishan FK. Sodium butyrate stimulates NHE8 expression via its role on activating NHE8 basal promoter activity. Am J Physiol Gastrointest Liver Physiol. 2015;309:G500–G505.CrossRef Xu H, McCoy A, Li J, Zhao Y, Ghishan FK. Sodium butyrate stimulates NHE8 expression via its role on activating NHE8 basal promoter activity. Am J Physiol Gastrointest Liver Physiol. 2015;309:G500–G505.CrossRef
38.
go back to reference Mangian HF, Tappenden KA. Butyrate increases GLUT2 mRNA abundance by initiating transcription in Caco2-BBe cells. JPEN J Parenter Enteral Nutr. 2009;33:607–617.CrossRef Mangian HF, Tappenden KA. Butyrate increases GLUT2 mRNA abundance by initiating transcription in Caco2-BBe cells. JPEN J Parenter Enteral Nutr. 2009;33:607–617.CrossRef
39.
go back to reference Zeissig S, Fromm A, Mankertz J, et al. Butyrate induces intestinal sodium absorption via Sp3-mediated transcriptional up-regulation of epithelial sodium channels. Gastroenterology. 2007;132:236–248.CrossRef Zeissig S, Fromm A, Mankertz J, et al. Butyrate induces intestinal sodium absorption via Sp3-mediated transcriptional up-regulation of epithelial sodium channels. Gastroenterology. 2007;132:236–248.CrossRef
40.
go back to reference Subramanian VS, Ghosal A, Kapadia R, Nabokina SM, Said HM. Molecular mechanisms mediating the adaptive regulation of intestinal riboflavin uptake process. PLoS ONE. 2015;10:e0131698.CrossRef Subramanian VS, Ghosal A, Kapadia R, Nabokina SM, Said HM. Molecular mechanisms mediating the adaptive regulation of intestinal riboflavin uptake process. PLoS ONE. 2015;10:e0131698.CrossRef
41.
go back to reference Sato T, Stange DE, Ferrante M, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology. 2011;141:1762–1772.CrossRef Sato T, Stange DE, Ferrante M, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology. 2011;141:1762–1772.CrossRef
42.
go back to reference Tsuruta T, Saito S, Osaki Y, et al. Organoids as an ex vivo model for studying the serotonin system in the murine small intestine and colon epithelium. Biochem Biophys Res Commun. 2016;474:161–167.CrossRef Tsuruta T, Saito S, Osaki Y, et al. Organoids as an ex vivo model for studying the serotonin system in the murine small intestine and colon epithelium. Biochem Biophys Res Commun. 2016;474:161–167.CrossRef
43.
go back to reference Anandam KY, Srinivasan P, Subramanian VS, Said HM. Molecular mechanisms involved in the adaptive regulation of the colonic thiamin pyrophosphate uptake process. Am J Physiol Cell Physiol. 2017;313:C655–C663.CrossRef Anandam KY, Srinivasan P, Subramanian VS, Said HM. Molecular mechanisms involved in the adaptive regulation of the colonic thiamin pyrophosphate uptake process. Am J Physiol Cell Physiol. 2017;313:C655–C663.CrossRef
44.
go back to reference Livek KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta DeltaC (T)) method. Methods. 2001;25:402–408.CrossRef Livek KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta DeltaC (T)) method. Methods. 2001;25:402–408.CrossRef
45.
go back to reference Lakhan R, Subramanian VS, Said HM. Role of MicroRNA-423-5p in posttranscriptional regulation of the intestinal riboflavin transporter-3. Am J Physiol Gastrointest Liver Physiol. 2017;313:G589–G598.CrossRef Lakhan R, Subramanian VS, Said HM. Role of MicroRNA-423-5p in posttranscriptional regulation of the intestinal riboflavin transporter-3. Am J Physiol Gastrointest Liver Physiol. 2017;313:G589–G598.CrossRef
46.
go back to reference Subramanian VS, Sabui S, Teafatiller T, Bohl JA, Said HM. Structure/functional aspects of the human riboflavin transporter-3 (SLC52A3): role of the predicted glycosylation and substrate-interacting sites. Am J Physiol Cell Physiol. 2017;313:C228–C238.CrossRef Subramanian VS, Sabui S, Teafatiller T, Bohl JA, Said HM. Structure/functional aspects of the human riboflavin transporter-3 (SLC52A3): role of the predicted glycosylation and substrate-interacting sites. Am J Physiol Cell Physiol. 2017;313:C228–C238.CrossRef
47.
go back to reference Subramanian VS, Srinivasan P, Said HM. Uptake of ascorbic acid by pancreatic acinar cells is negatively impacted by chronic alcohol exposure. Am J Physiol Cell Physiol. 2016;311:C129–C135.CrossRef Subramanian VS, Srinivasan P, Said HM. Uptake of ascorbic acid by pancreatic acinar cells is negatively impacted by chronic alcohol exposure. Am J Physiol Cell Physiol. 2016;311:C129–C135.CrossRef
48.
go back to reference Reidling JC, Nabokina SM, Said HM. Molecular mechanisms involved in the adaptive regulation of human intestinal biotin uptake: a study of the hSMVT system. Am J Physiol Gastrointest Liver Physiol. 2007;292:G275–G281.CrossRef Reidling JC, Nabokina SM, Said HM. Molecular mechanisms involved in the adaptive regulation of human intestinal biotin uptake: a study of the hSMVT system. Am J Physiol Gastrointest Liver Physiol. 2007;292:G275–G281.CrossRef
49.
go back to reference Li G, Reinberg D. Chromatin higher-order structures and gene regulation. Curr Opin Genet Dev. 2011;21:175–186.CrossRef Li G, Reinberg D. Chromatin higher-order structures and gene regulation. Curr Opin Genet Dev. 2011;21:175–186.CrossRef
50.
go back to reference Vidali G, Boffa LC, Bradbury EM, Allfrey VG. Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci USA. 1978;75:2239–2243.CrossRef Vidali G, Boffa LC, Bradbury EM, Allfrey VG. Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci USA. 1978;75:2239–2243.CrossRef
51.
go back to reference Bogliotti YS, Ross PJ. Mechanisms of histone H3 lysine 27 trimethylation remodeling during early mammalian development. Epigenetics. 2012;7:976–981.CrossRef Bogliotti YS, Ross PJ. Mechanisms of histone H3 lysine 27 trimethylation remodeling during early mammalian development. Epigenetics. 2012;7:976–981.CrossRef
52.
go back to reference Sabui S, Subramanian VS, Kapadia R, Said HM. Adaptive regulation of pancreatic acinar mitochondrial thiamin pyrophosphate uptake process: possible involvement of epigenetic mechanism(s). Am J Physiol Gastrointest Liver Physiol. 2017;313:G448–G455.CrossRef Sabui S, Subramanian VS, Kapadia R, Said HM. Adaptive regulation of pancreatic acinar mitochondrial thiamin pyrophosphate uptake process: possible involvement of epigenetic mechanism(s). Am J Physiol Gastrointest Liver Physiol. 2017;313:G448–G455.CrossRef
53.
go back to reference Ghosal A, Sabui S, Said HM. Identification and characterization of the minimal 5′-regulatory region of the human riboflavin transporter-3 (SLC52A3) in intestinal epithelial cells. Am J Physiol Cell Physiol. 2015;308:C189–C196.CrossRef Ghosal A, Sabui S, Said HM. Identification and characterization of the minimal 5′-regulatory region of the human riboflavin transporter-3 (SLC52A3) in intestinal epithelial cells. Am J Physiol Cell Physiol. 2015;308:C189–C196.CrossRef
Metadata
Title
Sodium Butyrate Enhances Intestinal Riboflavin Uptake via Induction of Expression of Riboflavin Transporter-3 (RFVT3)
Authors
Veedamali S. Subramanian
Subrata Sabui
Christopher W. Heskett
Hamid M. Said
Publication date
01-01-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5305-z

Other articles of this Issue 1/2019

Digestive Diseases and Sciences 1/2019 Go to the issue

Multicenter Seminars: IBD (MUSE: IBD)

Introduction to the IBD Case Conference Series

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.